Beyond Quality Of Life
Company

For a healthy and safe life in everyone's daily lives that we dream of...

TISSUE DONATION SAVES LIVES.

Corporate history

THE HISTORY OF INNOVATION IN DOF

DOF Inc. has pioneered the convergence of NT/BT in Korea.
Now, we're going to leap to the world to create better business value with NT/BT convergence innovation.

2023

  • Obtained GTP enlargement certificate by Government (+5,693 ft2)
  • GMP Factory Branch Registration
  • Round B Investment Attraction (KRW 15 B.)
  • Head office expansion relocation
Establishment of Medical Device GMP Factory

2022

  • Bridge investment attraction (6.1 billion won)
  • Opening of Seoul Sales Office (Songpa) and Opening of Medical Device Distribution Business
  • ISO 9001, 14001, 45001, 13485 certification
  • Establishment of Medical Device GMP Factory

2021

  • Obtained GTP certificate by Government (12,098 ft2)
  • Tissue-derived filler non-clinical test
  • Round A Investment Attraction (KRW 6 B.)
  • Certified as a material/part/equipment specialized company
  • Relocation of Head office from Seongnam to Dongtan

2020

  • Finished optimizing all tissue decellularization technologies, including fat
  • Complete development of Nerve Graft for implantation
  • Free A investment attraction (1.8 billion won)
Finished optimizing all tissue decellularization technologies, including fat

2019

  • Tissue decellularization technology optimization completed

2018

  • Securing ECM mass extraction technology
  • Applications and registration of domestic and international related patents
Securing ECM mass extraction technology

2017

  • Enterprise-affiliated research institutes and venture registration

2016

  • Completed development of NT-based coating liquid and film
  • Initiate patent application and development of ECM extraction and decellular technology

2015

  • Start-up as a nanotechnology R&D company